Bortezomib (PS-341, Velcade) is a novel, first-in-class proteasomeinhibitor with antitumor activity against a number of hematologic andnonhematologic malignancies.
Terri Davidson, PharmD
Advertisement
Articles by Terri Davidson, PharmD
Advertisement
Latest Updated Articles
- Pharmacology, Pharmacokinetics, and Practical Applications of Bortezomib
Published: December 1st 2004 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Chlorotoxin-Directed Cell Therapy May Have Useful Mechanism in Glioblastoma
2
Novel IL-2 Therapy Combo Yields Initial Responses in Nonsquamous NSCLC
3
Could Scorpion Venom Component Play a Role in Glioblastoma Management?
4
How Dato-DXd and the TROPION Trials Are Transforming Solid Tumor Research
5
